Showing results (91-100 of 253) with videos related to

Sort By:
Pageof 26
Cancer Immunology, Immunotherapy : CII|April 5, 2011
Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myelomaLarry D Anderson, Danielle R Cook, Tori N Yamamoto, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2005
Cytomegalovirus disease before hematopoietic cell transplantation as a risk for complications after transplantationBettina C Fries, Stanley R Riddell, Hyung W Kim, et al.
Blood|July 17, 2009
Safety and immunologic effects of IL-15 administration in nonhuman primatesCarolina Berger, Michael Berger, Robert C Hackman, et al.
The Journal of Experimental Medicine|September 10, 2003
Restoration of CD28 expression in CD28- CD8+ memory effector T cells reconstitutes antigen-induced IL-2 productionMax S Topp, Stanley R Riddell, Yoshiki Akatsuka, et al.
The Journal of Clinical Investigation|April 26, 2016
CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patientsCameron J Turtle, Laïla-Aïcha Hanafi, Carolina Berger, et al.
Blood Advances|January 17, 2025
Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALLJordan Gauthier, Emily C Liang, Jennifer J Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2009
Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemiaTetsuya Nishida, Michael Hudecek, Ana Kostic, et al.
Cancer Discovery|March 23, 2018
Chimeric Antigen Receptor T Cell-Mediated Neurotoxicity in Nonhuman PrimatesAgne Taraseviciute, Victor Tkachev, Rafael Ponce, et al.
The Journal of Infectious Diseases|August 27, 2002
Association between immune recovery uveitis and a diverse intraocular cytomegalovirus-specific cytotoxic T cell responseHelen P Mutimer, Yoshiki Akatsuka, Thomas Manley, et al.
British Journal of Haematology|April 9, 2005
A UGT2B17-positive donor is a risk factor for higher transplant-related mortality and lower survival after bone marrow transplantationSeitaro Terakura, Makoto Murata, Tetsuya Nishida, et al.
Pageof 26